Skip to main content
. 2025 May 4;70(6):2016–2020. doi: 10.1007/s10620-025-09068-x

Table 2.

Rates of anti-vinculin level normalization in patients who received antibody-depleting therapies (intravenous immunoglobulin [IVIG] or plasmapheresis exchange [PLEX]) vs. those undergoing usual care

Antibodies normalized Antibodies abnormal Total
IVIG/PLEX 5 3 8
Usual care 4 14 18
Total 9 17 P = 0.046